We use cookies to improve our services and to provide you with tailored content for an improved experience. By clicking "Accept", you consent to cookies.
On August 3, the Houston community was given the gift of community health education to adults and kids alike by some very eager young scholars.
In kicking off the upcoming school year, student pharmacists of the University of Houston College of Pharmacy (UHCOP) came together in support of efforts by Mayor John Whitmire in providing elementary students with educational health activities. Adults were also given the opportunity to participate in health screenings. This event was an excellent opportunity to uplift health knowledge in Houston to improve decision-making across all ages.
Empowering Houston with Health Education
Students were especially proud of their hard work in that the UHCOP's American Pharmacist Association-Academy of Student Pharmacists (APhA-ASP) helped to coordinate the event with faculty advisors
By The Revelation Pharma Marketing Team / Lexi J., BHA., MBA (Marketing Assoc. of Patient Partnerships), Haleigh Wilkes, PharmD., & Joseph Drummond, PharmD.
In the world of pharmaceuticals, compounding pharmacies play a critical role in tailoring medications to meet the unique needs of patients. But not all compounding pharmacies are created equal. There are two primary types: 503A and 503B. Understanding the differences between these two can help you make more informed decisions about your healthcare. In this article, we'll break down these distinctions and explore the relevance of this topic to Revelation Pharma and the communities we serve.
Understanding 503A and 503B Compounding Pharmacies
The distinction between 503A and 503B compounding pharmacies stems from the Drug Quality and Security Act (DQSA) of 2013. This act was introduced to enhance the safety and quality of compounded medications.
Compounders can help relieve drug shortages, says Revelation Pharma’s CEO, but they need help from the FDA. Shawn Hodges was interviewed for the latest edition of Pharmaceutical Executive for a piece called “Drug Shortages May Have a Compounding Solution” where he discussed how 503B pharmacies can fill the gaps caused by commercial pharma shortages and logistics issues.
“If you look at the problem in general, the shortages are being caused by manufacturing problems, supply chain issues, economic factors, and regulatory issues. There are opportunities in certain instances where compounding pharmacies can fill the void until the manufacturers are able to produce the products.”
Shawn is just one of the amazing team members at Revelation Pharma, which isn't surprising — Revelation is
Revelation Pharma is expanding literally from coast to coast with its acquisitions of Taylors Pharmacy in Florida and Key Compounding in Washington State. There are now 16 members of the Revelation family.
Are you a compounding pharmacy owner?
Join our vision — consider becoming part of the Revelation Pharma family! Click here for more info.
The acquisition helps Revelation Pharma, a national network of 503A and 503B compounding pharmacies, spread its dedication to providing industry-best patient care and solutions, while making it more convenient for more patients to access Revelation’s vast range of compounding services.
Taylors Pharmacy is a thriving nationwide independent pharmacy based in Florida but licensed in more than 41 states. It offers a variety of compounding
